Report Description
Botanical and plant derived drugs contain active ingredients derived from plants. The botanical drug is a mixture of plant materials that include whole plant, part of plants, fungi or algae. Plants have been used as a source of medicine since past, owing to side effects caused due to consumption of synthetic drugs the botanical and plant derived drugs are preferred over the synthetic drugs.
Furthermore, the botanical drugs are clinically evaluated for safety and efficacy just as conventional drugs. Besides, this legalization of medical cannabis is also expected to foster growth of the botanical and plant derived drugs market.
Market Dynamics
The global botanical and plant derived drugs market is projected to witness significant growth over the forecast period, owing to legalization of medical cannabis. Medical cannabis was legalized in the Czech Republic, in 2013, Argentina and Chile in 2015, and in 2016, marijuana legalization in America reached a tipping point, as the medical marijuana became legal in some of the states.
Hence, many manufacturers are focused on research and development on medical cannabis to launch new drugs. For instance, one of the drug by GW Pharmaceuticals, Epidiolex consists of cannabidivarin (CBDV) is in developmental process, which will be used in clinical trials for treatment resistant epilepsy, supported by NSW and Queensland government in 2016.
Furthermore, increasing number of chronic disease supports the growth of botanical and plant derived drugs, as lung cancer accounts for the leading cause of death in the Eastern, Southern and Southeastern Asia. The region holds for 56% of the world's population and contributes to 44% of the total cancer cases worldwide according to the statistics mentioned in the Cancer Atlas.
.Key features of the study:
• This report provides in-depth analysis of the Botanical and plant derived drugs market size (US$ Million) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period: 2018 - 2026, considering 2017 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global botanical and plant derived drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key companies covered as a part of this study include Bayer Healthcare, GlaxoSmithKline, Pfizer, Inc. Sanofi, Actelion Pharmaceuticals, Aimil Pharmaceuticals, Allergan, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Concordia Pharmaceuticals, GW Pharmaceuticals, LEO Pharma, MEDICAGO, and Merck.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, market expansion, and marketing tactics.
• The global botanical and plant derived drugs market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for botanical and plant derived drugs market, research and consulting firms, new entrants, and financial analysts.
Detailed Segmentation:
• Global Botanical and Plant Derived Drugs Market, By Source:
o Plant
o Algae
o Macroscopic fungi
o Others
• Global Botanical and Plant Derived Drugs Market, By Dosage Form:
o Pills
o Tablets
o Capsules
o Injection
• Global Botanical and Plant Derived Drugs Market, By Therapeutic Application :
o Central Nervous System
o Cardiovascular Diseases
o Infectious Diseases
o Respiratory Diseases
o Others
• Global Botanical and Plant Derived Drugs Market, By Region:
o North America
o North America Botanical and Plant Derived Drugs Market, By Source
• Plant
• Algae
• Macroscopic fungi
• Others
o North America Botanical and Plant Derived Drugs Market, By Dosage Form
• Pills
• Tablets
• Capsules
• Injection
o North America Botanical and Plant Derived Drugs Market, By Therapeutic Application :
• Central Nervous System
• Cardiovascular Diseases
• Infectious Diseases
• Respiratory Diseases
• Others
o North America Botanical and Plant Derived Drugs Market, By Countries
• U.S.
• Canada
o Europe
o Europe Botanical and Plant Derived Drugs Market, By Source
• Plant
• Algae
• Macroscopic fungi
• Others
o Europe Botanical and Plant Derived Drugs Market, By Dosage Form
• Pills
• Tablets
• Capsules
• Injection
o Europe Botanical and Plant Derived Drugs Market, By Therapeutic Application :
• Central Nervous System
• Cardiovascular Diseases
• Infectious Diseases
• Respiratory Diseases
• Others
o Europe Botanical and Plant Derived Drugs Market, By Countries
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
o Asia Pacific
o Asia Pacific Botanical and Plant Derived Drugs Market, By Source
• Plant
• Algae
• Macroscopic fungi
• Others
o Asia Pacific Botanical and Plant Derived Drugs Market, By Dosage Form
• Pills
• Tablets
• Capsules
• Injection
o Asia Pacific Botanical and Plant Derived Drugs Market, By Therapeutic Application :
• Central Nervous System
• Cardiovascular Diseases
• Infectious Diseases
• Respiratory Diseases
• Others
o Asia Pacific Botanical and Plant Derived Drugs Market, By Countries
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
o Latin America
o Latin America Botanical and Plant Derived Drugs Market, By Source
• Plant
• Algae
• Macroscopic fungi
• Others
o Latin America Botanical and Plant Derived Drugs Market, By Dosage Form
• Pills
• Tablets
• Capsules
• Injection
o Latin America Botanical and Plant Derived Drugs Market, By Therapeutic Application :
• Central Nervous System
• Cardiovascular Diseases
• Infectious Diseases
• Respiratory Diseases
• Others
o Latin America Botanical and Plant Derived Drugs Market, By Countries
• Brazil
• Mexico
• Rest of Latin America
o Middle East
o Middle East Botanical and Plant Derived Drugs Market, By Source
• Plant
• Algae
• Macroscopic fungi
• Others
o Middle East Botanical and Plant Derived Drugs Market, By Dosage Form
• Pills
• Tablets
• Capsules
• Injection
o Middle East Botanical and Plant Derived Drugs Market, By Therapeutic Application :
• Central Nervous System
• Cardiovascular Diseases
• Infectious Diseases
• Respiratory Diseases
• Others
o Middle East Botanical and Plant Derived Drugs Market, By Countries
• GCC
• Israel
• Rest of Middle East
o Africa
o Africa Botanical and Plant Derived Drugs Market, By Source
• Plant
• Algae
• Macroscopic fungi
• Others
o Africa Botanical and Plant Derived Drugs Market, By Dosage Form
• Pills
• Tablets
• Capsules
• Injection
o Africa Botanical and Plant Derived Drugs Market, By Therapeutic Application :
• Central Nervous System
• Cardiovascular Diseases
• Infectious Diseases
• Respiratory Diseases
• Others
o Africa Botanical and Plant Derived Drugs Market, By Countries
• North Africa
• Central Africa
• South Africa
• Company Profiles
o Bayer Healthcare*
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o GlaxoSmithKline
o Pfizer,Inc.
o Sanofi
o Actelion Pharmaceuticals
o Aimil Pharmaceuticals
o Allergan
o AstraZeneca
o Boehringer Ingelheim
o GW Pharmaceuticals
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Source
o Market Snippet, By Dosage Form
o Market Snippet, By Therapeutic Application
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Recent product launches
o Regulatory Scenario
o Awareness initiatives
o PEST Analysis
o PORTER's Analysis
o Epidemiology
4. Global Botanical and Plant Derived Drugs Market, By Source, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2017 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Plant
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Algae
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Macroscopic fungi
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
5. Global Botanical and Plant Derived Drugs Market, By Dosage Form, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2017 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o Pills
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Tablets
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Capsules
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Injection
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
6. Global Botanical and Plant Derived Drugs Market, By Therapeutic Application, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2017 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o Central Nervous System
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Cardiovascular Diseases
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Infectious Diseases
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Respiratory Diseases
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
7. Global Botanical and Plant Derived Drugs Market, By Regions, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2017 and 2026 (%)
o Y-o-Y Growth Analysis, By Region, 2016 - 2026
o Regional Trends
o North America
o Market Size and Forecast, By Source, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Countries, 2016 - 2026, (US$ Million)
• U.S.
• Canada
o Europe
o Market Size and Forecast, By Source, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Countries, 2016 - 2026, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
o Latin America
o Market Size and Forecast, By Source, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Countries, 2016 - 2026, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
o Asia Pacific
o Market Size and Forecast, By Source, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Countries, 2016 - 2026, (US$ Million)
• China
• India
• Japan
• Australia
• ASEAN
• South Korea
• Rest of Asia Pacific
o Middle East
o Market Size and Forecast, By Source, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Countries, 2016 - 2026, (US$ Million)
• GCC
• Israel
• Rest of Middle East
o Africa
o Market Size and Forecast, By Source, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Countries, 2016 - 2026, (US$ Million)
• North Africa
• Central Africa
• South Africa
8. Competitive Landscape
o Company Profiles
o Bayer Healthcare
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
o GlaxoSmithKline
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
o Pfizer, Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
o Sanofi
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
o Actelion Pharmaceuticals
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
o Aimil Pharmaceuticals
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
o Allergan
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
o AstraZeneca
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
o Boehringer Ingelheim
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
o GW Pharmaceuticals
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About Us and Sales Contact
*Browse 35 market data tables and 41 figures on "Global Botanical and Plant Derived Drugs Market- Global forecast to 2026".
Request Discount 
Inquire Before Buy
